Kyriakopoulos, Christos E.
Braden, Amy M.
Kolesar, Jill M.
Eickhoff, Jens C.
Bailey, Howard H.
Heideman, Jennifer
Liu, Glenn
Wisinski, Kari B.
Funding for this research was provided by:
National Cancer Institute (P30 CA014520, U01CA062491-19S1)
Article History
Received: 9 November 2016
Accepted: 13 December 2016
First Online: 21 December 2016
Compliance with ethical standards
:
: All authors have declared no conflict of interest.
: Funding was provided by the NCI Cancer Center Support Grant P30 CA014520 to University of Wisconsin Carbone Cancer Center and NCI U01CA062491-19S1 Early Clinical Trials of Anti-Cancer Agents with Phase I Emphasis.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.